Overview

A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacteriologic efficacy in those with initial culture positive specimens with different dosages of faropenem
Phase:
Phase 2
Details
Lead Sponsor:
Replidyne
Treatments:
beta-Lactams